Eukaryotic Initiation Factor 4E phosphorylation acts a switch for its binding to 4E-BP1 and mRNA cap assembly

Area of Science:

• Molecular Biology
• Cancer Research
• Translational Regulation

Background:

• Translational regulation is crucial in cancer development.
• eIF4E (Eukaryotic Initiation Factor 4E) is implicated in tumor progression by up-regulating cap-dependent translation.
• eIF4E is over-expressed in many human cancers.

Purpose of the Study:

• To investigate the role of eIF4E phosphorylation in tumorigenesis.
• To determine whether eIF4E phosphorylation or 4E-BP1 phosphorylation governs eIF4E-4EBP1 binding.
• To elucidate how eIF4E phosphorylation affects its availability for cap-assembly.

Main Methods:

• Investigated the binding of phosphorylated and dephosphorylated eIF4E to 4E-BP1.
• Assessed the influence of 4E-BP1 phosphorylation on eIF4E binding.
• Examined eIF4E's role in cap-assembly formation in a phosphorylation-dependent manner.

Main Results:

• Phosphorylated eIF4E is not sequestered by 4E-BP1.
• Dephosphorylated eIF4E binds strongly to 4E-BP1, irrespective of 4E-BP1's phosphorylation status.
• eIF4E phosphorylation, not 4E-BP1, governs its availability for cap-assembly.

Conclusions:

• eIF4E's tumorigenic property is primarily determined by its phosphorylation state.
• eIF4E phosphorylation, rather than 4E-BP1, regulates eIF4E-4EBP1 interaction.
• Phosphorylation controls eIF4E's availability for cap-dependent translation initiation in cancer.